复方甘草酸苷治疗抗结核药物性肝炎的疗效观察  被引量:3

Therapeutic Effects of Compound Glycyrrhizin on Patients with Hepatitis Induced by Anti-tuberculosis Drugs

在线阅读下载全文

作  者:谢俊平[1] 陈创坤 

机构地区:[1]广东省汕头市澄海区人民医院内二科,广东汕头515800

出  处:《河北医学》2008年第11期1286-1289,共4页Hebei Medicine

摘  要:目的:探讨复方甘草酸苷在治疗抗结核药物性肝炎中的作用。方法:选择结核病治疗中发生药物性肝炎并停用抗结核治疗药物患者48例,随机分为治疗组24例(常规治疗+复方甘草酸苷:复方甘草酸苷注射液60 ml加5%葡萄糖注射液250ml,静脉滴注,每日1次)和对照组24例(常规治疗组),4周为1疗程;对两组患者肝损害情况(ALT、AST、T-BIL)及预后进行观察比较。结果:两组患者症状、体征的恢复无明显差异(P>0.05)。治疗组显效及有效24例(100.0%),对照组显效及有效19例(79.2%),治疗组肝功能损害恢复情况优于对照组,两组差异显著(P<0.05))。结论:在结核患者进行抗结核治疗过程中,应加强肝功能监测;复方甘草酸苷治疗抗结核药物引起的药物性肝炎疗效显著。Objective: To investigate the efficacy of compound glycyrrhizin on patients with hepatitis associated with anti - tuberculosis drugs. Methods :48 inpatients with hepatitis due to anti - tuberculosis drugs were randomly divided into two groups: treatment group (24 patients )received routine therapy plus compound glycyrrhizin : compound glycyrrhizin for injection 60 ml and control group (24 patients ) received routine therapy for 4 5% glucose weeks. The solution 250 ml ( iv gtt, qd ). The damages of hepatic funtion ( ALT, AST, T- BIL ) and prognosis were observed and compared between the two groups. Results :The recovery of symptoms and signs were not' different significantly between the two groups ( p 〉 0.05 ). 24 cases patients ( 100% ) have completely or partly response in the treatment group, while 19 cases patients (79.2% ) have completely or partly response in the control group. The recovery of hepatic function is superior in the treatment group compared with the control group ( p 〈 0.05 ). Conclusion: Hepatic function must be detected strengthly among the therapy of anti - tuberculosis; the efficacy of compound glycyrrhizin on patients with hepatitis associated with anti -tuberculosis drugs is significant.

关 键 词:结核病 药物性肝损害 复方甘草酸苷 

分 类 号:R595.3[医药卫生—内科学] R575.1[医药卫生—临床医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象